Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-27 @ 9:28 PM
Study NCT ID:
NCT04575961
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-23
First Post:
2020-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
Sponsor:
North Eastern German Society of Gynaecological Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-07
First Submit QC Date:
None
Study First Post Date:
2020-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-20
Last Update Post Date:
2025-05-23
Last Update Post Date Type:
ACTUAL